QRVO
8
4
MTCH
42
5
DE
56
10
CMS
60
2
HBAN
56
2
CFG
64
2
HSIC
51
-3
AFL
49
3
BXP
52
2
CTAS
59
4
KEY
43
3
GT
56
2
KHC
11
2
ZTS
49
2
LRCX
45
6
PNR
69
4
COST
63
5
KIM
76
2
GOOGL
45
-9
MRK
27
5
QRVO
8
4
MTCH
42
5
DE
56
10
CMS
60
2
HBAN
56
2
CFG
64
2
HSIC
51
-3
AFL
49
3
BXP
52
2
CTAS
59
4
KEY
43
3
GT
56
2
KHC
11
2
ZTS
49
2
LRCX
45
6
PNR
69
4
COST
63
5
KIM
76
2
GOOGL
45
-9
MRK
27
5
Financhill
Back

Edgewise Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

EWTX
Edgewise Therapeutics

Last Price:
32.40
Seasonality Move:
66.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Edgewise Therapeutics Stock Forecast

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 149.5% based on the past 3 years of stock performance.
  • Edgewise Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Edgewise Therapeutics Stock Undervalued?
    The current Edgewise Therapeutics [EWTX] share price is $31.98. The Score for EWTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 149.5% based on the past 3 years of stock performance.

Edgewise Therapeutics Stock Rating

Buy
56
Edgewise Therapeutics (EWTX) is a Buy

Is Edgewise Therapeutics overpriced?

  • Edgewise Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Edgewise Therapeutics Stock Price History

Is EWTX stock going to rise?

  • The current trend is relatively stagnant and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com

52-Week Data

52-Week High:
38.12
52-Week Low:
5.93

Prediction Charts

Market Cap:
3.03B
Price in USD:
31.98
Volume:
376.59K
Beta:
0.15

Technical Analysis

SMA50:
30.30
SMA100:
24.63
SMA200:
21.04
52-Wk Change:
404.42%

Stock Predictions

  • Is Edgewise Therapeutics stock public?
    Yes, Edgewise Therapeutics is a publicly traded company.
  • What is the Edgewise Therapeutics stock quote today?
    The Edgewise Therapeutics stock price is 31.98 USD today.
  • How to buy Edgewise Therapeutics stock online?
    You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 33.94 34.48 35.14 33.07
Nov-5 34.58 35.94 36.09 33.64
Nov-6 37.00 36.61 37.29 35.66
Nov-7 36.75 35.43 37.00 34.39
Nov-8 34.96 36.38 36.70 34.79
Nov-11 37.00 35.33 38.12 35.21
Nov-12 35.24 35.22 35.99 34.00
Nov-13 35.45 33.26 35.79 33.00
Nov-14 32.40 32.87 33.99 32.40
Nov-15 33.01 31.44 33.21 31.38
Nov-18 31.05 30.79 31.18 29.82
Nov-19 30.37 31.51 31.72 29.96
Nov-20 31.44 31.95 32.08 31.06
Nov-21 32.37 31.98 32.80 31.71

Edgewise Therapeutics Earnings

Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics Forecast Revenue Growth

Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.35 per share.

* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.